Dr. Lal PathLabs Limited
LALPATHLAB
Rang in aandelen
#4525
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Aandeelprijs
$20.35
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$3.40B
Verandering (1 dag)
-0.86%
Verandering (1 jaar)
13.63%
Land
IN
Handel Dr. Lal PathLabs Limited (LALPATHLAB)
Categorie
Healthcare
Winst voor Dr. Lal PathLabs Limited (LALPATHLAB)
Winst in Jun 2026 TTM: $79.09M
Volgens de meest recente financiële verslagen van Dr. Lal PathLabs Limited bedraagt de huidige winst van het bedrijf $79.09M. In 2024 behaalde het bedrijf een winst van $60.62M, een stijging ten opzichte van de winst van 2023, die $41.84M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Dr. Lal PathLabs Limited van 2011 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $79.09M | 8.27% |
| 2025 | $73.05M | 20.51% |
| 2024 | $60.62M | 44.89% |
| 2023 | $41.84M | -33.14% |
| 2022 | $62.57M | 16.14% |
| 2021 | $53.88M | 30.72% |
| 2020 | $41.22M | -4.77% |
| 2019 | $43.28M | 7.84% |
| 2018 | $40.13M | 9.90% |
| 2017 | $36.52M | 20.54% |
| 2016 | $30.30M | 35.31% |
| 2015 | $22.39M | -3.94% |
| 2014 | $23.31M | 57.92% |
| 2013 | $14.76M | 12.68% |
| 2012 | $13.10M | 30.51% |
| 2011 | $10.04M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | 9,520.18% |
US
|
|
| $4.76B | 5,920.67% |
US
|
|
| $-252.70M | -419.49% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,996.24% |
US
|
